Protein flexibility and drug design: How to hit a moving target

Current Opinion in Chemical Biology

Volumn 6, Issue 4, 2002, Pages 447-452

  Carlson, Heather A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; LIGAND; PROTEIN;

COMPUTER AIDED DESIGN; COMPUTER PROGRAM; DRUG DESIGN; DRUG MANUFACTURE; DRUG TARGETING; HUMAN; NONHUMAN; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW;

EID: 0036680063     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00341-1     Document Type: Review

References (44)

1. High-throughput docking for lead generation
2. Accommodating protein flexibility in computational drug design
3. Why are proteins marginally stable?
4. An analysis of conformational changes upon protein-protein association: Implications for predictive docking
5. Analysis of a data set of paired uncomplexed protein structures: New metrics of side-chain flexibility and model evaluation
6. Side-chain flexibility in proteins upon ligand binding
7. Structural stability of binding sites: Consequences for binding affinity
8. Flexibility and packing in proteins
9. Folding funnels and binding mechanisms
10. Binding sites in Echerichia coli dihydrofolate reductase communicate by modulating the conformational ensemble
11. Multiple diverse ligands binding at a single protein site: A matter of pre-existing populations
12. Ligand docking to proteins with discrete side-chain flexibility
13. Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation
14. Harmonic modes as variables to approximately account for receptor flexibility in ligand-receptor docking simulations: Applications to DNA minor groove ligand complex
15. Fully flexible low-mode docking: Application to induced fit in HIV integrase
16. Parallel simulated tempering dynamics of ligand-protein binding with ensembles of protein conformations
17. Molecular docking to ensembles of protein structures
18. FlexE: Efficient molecular docking considering protein structure variations
19. Designing non-peptide peptidomimetics in the 21st century: Inhibitors targeting conformational ensembles
20. GRID/CPCA: A new computational tool to design selective ligands
21. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock
22. Developing a dynamic pharmacophore model for HIV-1 integrase
23. Method for including the dynamic fluctuations of a protein in computer-aided drug design
24. A method for including protein flexibility in protein-ligand docking: Improving tools for database mining and virtual screening
25. Screening a peptidyl database for potential ligands to proteins with side-chain flexibility
26. Flexibility screening for molecules interacting with proteins
27. Virtual screening with solvation and ligand-induced complementarity
28. Protein flexibility predictions using graph theory
29. Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking
30. Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystallographic refinement
31. Structural genomics programs at the US National Institute of General Medical Sciences
32. Industrial-scale, genomics-based drug design and discovery
33. Docking of small ligands to low-resolution and theoretically predicted receptor structures
34. Docking ligands onto binding site representations derived from proteins built by homology modelling
35. Chemogenomic approaches to drug discovery
36. Structure-based library design: Molecular modelling merges with combinatorial chemistry
37. Design, docking, and evaluation of multiple libraries against multiple targets
38. Genomics and antimicrobial drug discovery
39. New roles for structure in biology and drug discovery
40. Development of a new type of protease inhibitors, efficacious against FIV and HIV variants
41. Prediction of potential toxicity and side effect protein targets of a small molecule by ligand-protein inverse docking approach
42. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule
43. Complexity and simplicity of ligand-macromolecule interactions: The energy landscape perspective
44. Contributions to the binding free energy of ligands to avidin and streptavidin